|
 |
|
| AUDITED FINANCIAL RESULTS FOR THE QUARTER ENDED 30TH JUNE 2009 |
| (Rs. In Lacs) |
| PARTICULARS |
For the
Quarter Ended
|
For the
Quarter Ended
|
For the Year ended Ended |
30th
June 2009 |
30th
June 2008 |
31st
Mar 2009 |
| 1. |
(a) |
(Net) Sales / Income from operations |
11,490 |
10,171 |
37,650 |
| |
(b) |
Other Operating Income |
- |
- |
- |
| 2. |
Expenditure |
| |
(a). |
(Increase) / Decrease in stock in trade |
218 |
161 |
695 |
| |
(b). |
Consumption of raw materials. |
5,824 |
5,962 |
21,077 |
| |
(c). |
Purchase of Traded Goods |
1,730 |
850 |
3,443 |
| |
(d). |
Employees cost |
321 |
256 |
1,114 |
| |
(e). |
Depreciation |
328 |
257 |
1,104 |
| |
(f). |
Other expenditure |
1,443 |
1,303 |
5,648 |
| |
(g). |
Total Expenditure |
9,864 |
8,790 |
33,081 |
| 3. |
Profit from Operating before Other Income |
1,625 |
1,381 |
4,570 |
| 4. |
Other Income |
2 |
4 |
17 |
| 5. |
Profit before Interest & Exceptional Items |
1,627 |
1,385 |
4,587 |
| 6. |
Interest |
416 |
560 |
2,272 |
| 7. |
Profit after Interest but before Exceptional Items |
1,211 |
825 |
2,315 |
| 8. |
Exceptional Items |
- |
- |
- |
| 9. |
Profit from Ordinary Activities before Tax |
1,211 |
825 |
2,315 |
| 10. |
Tax Expenses (Includes) |
481 |
173 |
810 |
| |
|
Provision for Taxation |
413 |
107 |
540 |
| |
|
Provision for FBT |
- |
3 |
15 |
| |
|
Provision for Deffered Taxation |
68 |
63 |
255 |
| 11. |
Net profit from ordinary Activities after Tax |
731 |
652 |
1,505 |
| 12. |
Extraodinary Item (net of tax expenses ) |
|
|
|
| 13. |
Net Profit for the period |
731 |
652 |
1,505 |
| 14. |
Paid-up Equity Share Capital of Rs.10/- each. |
1,171 |
1,171 |
1,171 |
| 15. |
Reserves & Surplus (excluding revaluation reserves) |
- |
- |
10,827 |
| 16. |
Basic E P S (in Rs.) |
6.24 |
5.57 |
12.85 |
| 17. |
Public Shareholding |
|
|
|
| |
|
Number of Shares |
5329891 |
5932388 |
5495949 |
| |
|
Percentage of Total Shareholding |
45.52 |
50.67 |
46.94 |
| 18. |
Promoters & Promoter Group Shareholding** |
|
|
|
| |
a) |
Pledged/Encumbered |
|
|
|
| |
|
- Number of Shares |
NIL |
N.A |
NIL |
| |
|
-Percentage of shares( as a percentage of the total shareholding of promoter and promoter group) |
NIL |
N.A |
NIL |
| |
|
-Percentage of shares( as a percentage of total sharecapital of the Company) |
NIL |
N.A |
NIL |
| |
b) |
Non-encumbered |
|
|
|
| |
|
- Number of Shares |
6378659 |
N.A |
6212601 |
| |
|
-Percentage of shares( as a percentage of total shareholding of promoter and promoter group) |
100 |
N.A |
100 |
| |
|
-Percentage of shares (as a percentage of total sharecapital of the Company) |
54.48 |
N.A |
53.06 |
|
|
| Notes : |
| 1. |
The above results, reviewed by the Audit Committee, have been taken on record by the Board of Directors at their meeting held on 30th July, 2009. |
| 2. |
Company is operating as a Single Segment Company, engaged in pharmaceuticals business hence, the disclosure requirement as per AS - 17 'Segment Reporting' is not attracted. |
| 3. |
The figures of the previous periods have been regrouped and rearranged wherever necessary. |
| 4. |
Number of Investors complaints (i) received during the quarter : 4 (ii) redressed : 3 (iii) pending at the quarter end : 1. |
| For and on behalf of the Board |
| FOR AARTI DRUGS LIMITED |
| Place : Mumbai |
Harshit M. Savla |
| Date : 30th July, 2009 |
( Jt. Managing Director) |
|
|
|
|
|
 |
|
|
|
